Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Gastrointestinal Diseases 1Esophageal Squamous Cell Carcinoma 1

Interventions

Oxaliplatin 4Fluorouracil 4Magnetic Resonance Spectroscopy 35,10-methylenetetrahydrofolic acid 3Ocoxin 2Leucovorin 2Irinotecan 2Cyclophosphamide 2Bevacizumab 2trifluridine tipiracil drug combination 1sintilimab 1pralsetinib 1pembrolizumab 1napabucasin 1huachansu 1guadecitabine 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1S-1 plus cisplatin 1Pharmaceutical Preparations 1Pemetrexed 1Paclitaxel 1Oviposition 1Levoleucovorin 1Infliximab 1Imatinib Mesylate 1Gemcitabine 1Exercise Test 1Drainage 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Diseases × huachansu × Clear all
NCT00837239 2012-07-12

Huachansu & Gemcitabine in Pancreatic Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled
Gastrointestinal

Gastrointestinal Diseases, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡